Moderna (MRNA)

Moderna, Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA.

Company profile

MRNA, 0A45
Stephane Bancel
Fiscal year end
Former names
Moderna Therapeutics, Inc.
Brizo Ltd. • Moderna Australia Pty Ltd • Moderna Austria GmbH • Moderna Biopharma Canada Corporation • Moderna Biotech Ireland Limited • Moderna Biotech Securities, Inc. • Moderna Biotech UK Limited • Moderna Charitable Foundation, Inc. • Moderna Germany GmbH • Moderna Italy S.r.l. ...
IRS number

MRNA stock data

Investment data

Data from SEC filings
Securities sold
Number of investors


4 May 22
24 May 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 5.06B 5.06B 5.06B 5.06B 5.06B 5.06B
Cash burn (monthly) 600M 32.75M (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 1.07B 58.13M n/a n/a n/a n/a
Cash remaining 3.99B 5B n/a n/a n/a n/a
Runway (months of cash) 6.7 152.7 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
19 May 22 Bancel Stephane Common Stock Sell Dispose S Yes Yes 140.96 10,000 1.41M 6,884,880
18 May 22 Bancel Stephane Common Stock Gift Dispose G No Yes 0 4,000 0 5,411,946
18 May 22 Afeyan Noubar Common Stock Sell Dispose S No Yes 138.38 10,000 1.38M 2,567,209
16 May 22 Bancel Stephane Common Stock Other Acquire J No No 0 24,411 0 5,415,946
13 May 22 Stephen Hoge Common Stock Sell Dispose S No Yes 132.69 15,000 1.99M 1,622,820
13 May 22 Stephen Hoge Common Stock Option exercise Acquire M No Yes 0 10,000 0 1,637,820
13 May 22 Stephen Hoge Common Stock Option exercise Acquire M No Yes 10.9 5,000 54.5K 1,627,820
13 May 22 Stephen Hoge Stock Option Common Stock Option exercise Dispose M No Yes 0 10,000 0 7,431
13 May 22 Stephen Hoge Stock Option Common Stock Option exercise Dispose M No Yes 10.9 5,000 54.5K 76,972
12 May 22 Stephen Hoge Common Stock Sell Dispose S No Yes 121.1 5,000 605.5K 1,622,820
68.3% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 954 1076 -11.3%
Opened positions 121 211 -42.7%
Closed positions 243 243
Increased positions 381 391 -2.6%
Reduced positions 306 362 -15.5%
13F shares Current Prev Q Change
Total value 44.4B 64.71B -31.4%
Total shares 271.65M 272.61M -0.4%
Total puts 17.37M 25.45M -31.8%
Total calls 14.66M 17.61M -16.7%
Total put/call ratio 1.2 1.4 -18.0%
Largest owners Shares Value Change
Baillie Gifford & Co 45.63M $7.86B -0.3%
BLK Blackrock 28.67M $4.94B +3.7%
Vanguard 27.04M $4.66B -1.4%
Flagship Pioneering 17.58M $3.03B 0.0%
Flagship Ventures Fund IV General Partner 17.58M $0 0.0%
STT State Street 14.85M $2.56B -0.1%
Bancel Stephane 9.05M $2.3B 0.0%
Coatue Management 6.93M $1.19B +61.6%
Geode Capital Management 6.44M $1.11B +6.7%
Theleme Partners 6.34M $1.09B +26.2%
Largest transactions Shares Bought/sold Change
Norges Bank 0 -3.04M EXIT
Coatue Management 6.93M +2.64M +61.6%
BCS Barclays 1.31M -1.99M -60.2%
Renaissance Technologies 3.82M +1.98M +108.2%
FMR 2.25M -1.95M -46.5%
MS Morgan Stanley 2.91M -1.93M -39.9%
Theleme Partners 6.34M +1.31M +26.2%
BLK Blackrock 28.67M +1.01M +3.7%
DB Deutsche Bank AG - Registered Shares 1.81M +875.01K +94.1%
Aqr Capital Management 1.37M +847.32K +163.6%

Financial report summary

Management Discussion
  • older. Subsequently, we have also received authorization for our COVID-19 vaccine from health agencies in more than 70 countries and from the World Health Organization (WHO). Additional authorizations are currently under review in other countries. In addition, we have received authorization for our COVID-19 vaccine for use in adolescents in the European Union, the United Kingdom, Australia, Canada, Switzerland and other countries, and have pending applications for authorization to administer the vaccine to adolescents with regulatory agencies in the United States and other countries. In January 2022, we received full FDA approval for Spikevax to prevent COVID-19 in individuals 18 years of age and older in the United States.

Content analysis

H.S. sophomore Avg
New words: AACR, add, ago, al, Alnylam, AMC, American, assert, asserted, asserting, audited, Australian, average, belonging, biomarker, Biopharma, bivalent, bnAb, buildout, cationic, CEPI, Charitable, Coalition, complaint, composition, conference, continent, coupled, Court, Del, descent, difficult, display, distinct, District, domestically, ecosystem, ejection, elevated, eligible, endowment, enforce, envelope, EU, evolving, exhibiting, exiting, expenditure, face, failure, fewer, firm, fiscal, fraction, frequency, fulfill, fullest, Gavi, Genevant, germline, GmbH, guide, hemagglutinin, Hemisphere, hormone, HSV, induction, infringement, Kenya, label, lack, latent, launch, launching, lawsuit, left, length, linked, litigation, LVEF, main, malaria, mandatory, Memorandum, mentioned, monovalent, NA, neglected, network, neuraminidase, NIAID, NiV, Northern, Notification, Numerical, obsolescence, obsolete, OLE, Omicron, outcome, persistent, pledge, predominantly, priming, prioritize, rapid, Regional, repealed, safe, scrap, sequelae, sequential, slightly, soluble, source, sourcing, Southern, sponsorship, stable, step, stop, Swissmedic, TB, thereto, tract, tropical, UK, Understanding, Unregistered, unsaleable, unsuccessful, unused, upper, urgent, ventricular, VZV, widely, willfully, winter, write, Yen
Removed: achieve, acquiring, addressable, adjudicated, AETR, agreed, alliance, alternative, ancestral, approach, artery, barrier, baseline, began, billed, biology, body, boost, borrowing, Brazil, breadth, broad, budgeted, capitalizing, carefully, chosen, classified, collaborator, combining, commenced, comprise, core, coronary, correlated, counterparty, COVE, creating, creation, creditworthy, criteria, dedicated, deem, defend, deliver, deployment, desired, digital, disruption, diversity, doubling, enacted, Engine, enroll, entry, epithelial, escalation, ESPP, essential, execution, expectation, expend, expended, expensed, exploratory, expression, fatigue, figure, forced, formed, formulation, function, gB, generating, grafting, headache, hiring, hypothetical, immune, impaired, imputed, increasingly, incremental, independent, infect, infection, Initiative, injection, internationally, intrinsic, invest, investigate, IP, ischemic, iterative, July, led, Lonza, lose, MA, magnitude, maintaining, mature, maximize, median, membrane, mild, minimize, moderate, moderately, movement, multinational, multiplying, multivalent, myalgia, nonclinical, nonperformance, noting, Notwithstanding, occurred, operation, original, pain, paper, partnered, payout, pentamer, percent, perfunctory, periodic, pharmaceutical, pharmacology, planned, predict, preestablished, prepare, presently, preventive, procurement, professional, protect, protocol, PSU, qualified, range, ranging, realize, reassessed, recoverability, recoverable, reduced, reduction, regimen, regularly, released, remeasurement, reserved, resulted, reverse, reviewed, rolling, Rovi, RSU, sale, secure, seek, sensitivity, separately, seronegative, shipped, spectrum, stability, submission, successor, surgery, sustained, systolic, team, TeenCOVE, temporary, tenant, tissue, titer, trademark, transferred, ultimate, ultimately, uncorrelated, undergoing, uniformly, Union, unrelated, utilized, vaccinated, validate, vested, vesting, vial, weighing